Testing effectiveness (Phase 2)Study completedNCT02529930
What this trial is testing
An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)
Who this might be right for
High Grade Cervical Intraepithelial Neoplasia
Nykode Therapeutics ASA 34